Applicant Delay and PTA Reductions: How Your Prosecution Choices Affect Patent Term

Patent term adjustment (PTA) compensates applicants for USPTO delays — but the final PTA on any patent is reduced by periods of applicant delay, time during which the applicant failed to engage in reasonable efforts to conclude prosecution. Under 35 U.S.C. § 154(b)(2)(C), the USPTO subtracts applicant delay from the gross PTA to arrive at the net adjustment. These reductions can be significant: a single late response or poorly timed IDS filing can cost dozens or even hundreds of days of patent term. Understanding what triggers applicant delay — and how to avoid it — is one of the most practical things a patent attorney can do to protect their client's patent term.

Scope: This article covers the applicant delay provisions of 35 U.S.C. § 154(b)(2)(C) and the implementing regulations at 37 CFR 1.704. All examples assume US law and the current 20-year-from-filing term framework. For an overview of PTA generally, see our PTA vs PTE comparison.

The Statutory Framework for Applicant Delay

35 U.S.C. § 154(b)(2)(C) establishes two mechanisms for reducing PTA based on applicant conduct:

First, under § 154(b)(2)(C)(ii), applicant delay includes the cumulative total of any periods exceeding 3 months taken to respond to any notice from the Office making a rejection, objection, argument, or other request. This is the most common source of applicant delay and is implemented in 37 CFR 1.704(b).

Second, under § 154(b)(2)(C)(iii), the USPTO Director is authorized to prescribe regulations establishing additional circumstances that constitute a failure to engage in reasonable efforts. These are codified in 37 CFR 1.704(c), which defines over a dozen specific types of applicant conduct that generate PTA reductions.

The 3-Month Reply Deadline (37 CFR 1.704(b))

The most fundamental rule is simple: for every day beyond three months that an applicant takes to reply to an Office action or other USPTO notice, one day of PTA is subtracted. The three-month period is measured from the mailing date of the Office communication.

This means that requesting a standard extension of time to respond to a non-final or final Office action will always generate applicant delay. A one-month extension costs approximately 30 days of PTA. A three-month extension (responding at the six-month statutory deadline) costs approximately 90 days.

What Counts as a "Reply" After Final Rejection?

A critical nuance is that not every submission after a final rejection qualifies as a "reply" that stops the applicant delay clock. In Intra-Cellular Therapies, Inc. v. Iancu, 2018-1849 (Fed. Cir. 2019), the Federal Circuit upheld the USPTO's position that a response to a final Office action must comply with 37 CFR 1.113(c) — meaning the applicant must either cancel or appeal rejected claims, or file an RCE under 37 CFR 1.114.

In that case, the applicant filed an after-final amendment within three months that addressed all outstanding objections and rejections but continued to dispute a § 103 rejection using the same arguments the examiner had already found unpersuasive. The examiner issued an advisory action indicating the rejection was not overcome. The applicant then filed a second response adopting the examiner's suggestions, which led to allowance. The court held that only the second submission qualified as a proper reply, and the 21 days between the three-month deadline and the second response was properly assessed as applicant delay.

The practical lesson: after a final rejection, the applicant delay clock does not stop until the applicant files a submission that actually places the application in condition for further processing — either by canceling/appealing rejected claims or by filing an RCE.

USPTO Closings and the 3-Month Deadline

When the USPTO is closed due to weather or other emergencies, the closure is treated as a federal holiday under 35 U.S.C. § 21. If a three-month applicant response deadline falls on a closure date, the deadline extends to the next business day. This rule was confirmed in ArQule v. Kappos, 793 F.Supp.2d 214 (D.D.C. 2011), and is discussed in MPEP § 2732. The USPTO publishes its operating status on its Status page.

Specific Types of Applicant Delay Under 37 CFR 1.704(c)

Beyond the 3-month reply rule, 37 CFR 1.704(c) identifies specific prosecution events that generate PTA reductions. The most commonly encountered include:

Abandonment and Revival (§ 1.704(c)(3))

If an application is abandoned (including for late payment of the issue fee) and later revived, the period of abandonment counts as applicant delay. Under the 2020 Final Rule, the reduction runs from the date of abandonment until the earlier of the date the revival decision is mailed or four months after a grantable revival petition is filed. This revision, which shortened the reduction period by up to four months in some cases, was prompted by the Federal Circuit's decision in Supernus Pharmaceuticals, Inc. v. Iancu, 913 F.3d 1351 (Fed. Cir. 2019). See Supernus and Its Limits below.

Supplemental Replies and IDS Filings After a Reply (§ 1.704(c)(8))

Filing a supplemental reply or other paper after a reply has already been filed generates applicant delay measured from the day after the initial reply was filed until the supplemental paper is filed. The most common trigger is filing an IDS after an RCE or after responding to an Office action.

This reduction can be avoided by accompanying the IDS with a safe harbor statement under 37 CFR 1.704(d). See IDS Safe Harbor Statements below.

Post-Allowance Papers (§ 1.704(c)(10))

Filing a Rule 312 amendment, IDS (without a safe harbor statement), priority correction, or other paper after a notice of allowance generates applicant delay. Under the 2020 Final Rule, the reduction runs from the day after the notice of allowance until the date the paper was filed — a change that can actually increase the reduction compared to the prior rule, which measured from filing of the paper until the USPTO's response and was capped at four months.

However, the 2020 revision also carved out an important exception: papers expressly requested by the Office no longer generate applicant delay. This means if an examiner specifically requests a correction or submission in an interview summary or Office communication, responding to that request will not reduce PTA. Generic language in a notice of allowability suggesting that amendments may be filed does not qualify as an express request. See the 2020 Final Rule discussion for details.

Failure to Place Application in Condition for Examination (§ 1.704(c)(13))

If an application is not in "condition for examination" as defined in 37 CFR 1.704(f) within eight months of filing or national stage commencement, the excess time counts as applicant delay. This includes compliance with 37 CFR 1.52 formatting requirements.

In Lundbeck v. USPTO, 1:23-cv-1105 (E.D. Va. 2024), the court upheld a PTA reduction where the applicant's specification contained shaded tables that the USPTO deemed insufficiently clear for electronic reproduction. Even though the USPTO did not identify the defect for 10 months, the court held it was the applicant's responsibility to submit a conforming specification, and the delay was properly assessed from the eight-month mark until the corrected papers were filed.

Entity Status Misrepresentation (New for 2025)

In June 2025, the USPTO implemented a monetary fine and PTA penalty for false assertions or certifications concerning small or micro entity status. Under 37 CFR 1.704(c), any delay caused by the USPTO removing an application from examination to resolve a false entity status claim is treated as applicant delay, running from the date the USPTO issues a combined notice and order until all fee deficiencies and fines are paid.

IDS Safe Harbor Statements (37 CFR 1.704(d))

An applicant can avoid PTA reductions for IDS filings by including a safe harbor statement certifying that each item in the IDS was first cited in a communication from a foreign patent office or the USPTO in a related application not more than 30 days before the IDS was filed.

Since July 17, 2023, a Final Rule requires applicants to use USPTO Form PTO/SB/133 and document code "PTA.IDS" when making a safe harbor statement. Using the correct form and code allows the USPTO's automated PTA algorithm to properly account for the statement. Without them, the patentee must file a post-grant Application for PTA under 37 CFR 1.705(b) to obtain manual review — an extra step that requires a fee and has a deadline.

The USPTO's automated PTA calculation has historically failed to account for safe harbor statements even when properly filed, prompting the USPTO to implement an interim procedure allowing patentees to request recalculation using Form PTO/SB/134. See our article on verifying and challenging USPTO PTA calculations for details.

The Supernus Decision and Its Limits

Supernus Pharmaceuticals, Inc. v. Iancu, 913 F.3d 1351 (Fed. Cir. 2019) is the leading case on the limits of applicant delay reductions. The Federal Circuit held that the USPTO may not reduce PTA for periods during which there was no identifiable effort the applicant could have undertaken to conclude prosecution.

In Supernus, the applicant filed an RCE and then, 18 months later, received notice of an opposition filed at the European Patent Office citing 10 documents. The applicant filed an IDS disclosing those documents 100 days after learning of them. The USPTO assessed 646 days of applicant delay under § 1.704(c)(8) — measured from the day after the RCE until the IDS filing — even though the applicant could not have filed the IDS any earlier because the opposition documents did not yet exist for the first 546 of those days.

The court reversed, holding that the statute only permits reductions "equal to the period of time during which the applicant failed to engage in reasonable efforts." The 546-day period before the EPO notification was not a failure to engage in reasonable efforts because there was nothing the applicant could have done.

Supernus prompted the USPTO to revise six provisions of 37 CFR 1.704(c) through a 2020 Final Rule, aiming to better align reductions with actual periods of applicant inaction. However, the revisions are not uniformly favorable — in some cases (particularly post-allowance papers under § 1.704(c)(10)), the redefined measurement period can actually increase the reduction. Applicants should evaluate the net effect case by case.

Worked Example: How Applicant Delay Reduces PTA

Common Mistakes

• Assuming extensions of time are "free." Every day of extension beyond three months costs a day of PTA. A 2-month extension on every Office action in a prosecution with three actions costs roughly 180 days of patent term.
• Filing an IDS after an RCE without a safe harbor statement. This is one of the most common and most costly mistakes. If the IDS items were cited in a related foreign or domestic application within the last 30 days, use Form PTO/SB/133 and document code PTA.IDS.
• Filing post-allowance papers without considering PTA impact. Every paper filed after allowance (unless expressly requested by the examiner) generates applicant delay. Batch corrections before allowance when possible.
• Assuming after-final submissions stop the delay clock. A submission after final rejection must comply with 37 CFR 1.113(c) to qualify as a "reply." Continuing to argue rejected claims with the same arguments does not stop applicant delay from accruing.
• Not checking for USPTO closings. Weather closings and emergency closures extend the 3-month deadline. Failing to account for these can lead to overstated applicant delay — and understated PTA — on the USPTO's end.

Last reviewed: April 2026

Authorship: Written by the patentreply.ai editorial team. See our editorial methodology for how guides are drafted, sourced, and reviewed.

Legal disclaimer: This article is for informational purposes only and does not constitute legal advice. Consult a registered patent attorney or agent for advice specific to your situation. patentreply.ai is not a law firm.